82 results
Page 3 of 5
S-3ASR
1u5unl35
21 Nov 18
Automatic shelf registration
4:06pm
424B5
hs88gjemngo 4r
21 Sep 18
Prospectus supplement for primary offering
4:41pm
424B5
cjg6dx8kd45
20 Sep 18
Prospectus supplement for primary offering
4:24pm
8-K
pppnnlty ia720ipjug1
18 May 18
Fate Therapeutics and Memorial Sloan Kettering Cancer Center Expand Scope of License Agreement to include Gene-edited T-cell Immunotherapies
4:05pm
424B3
wfmc2n 9j14b
25 Jan 17
Prospectus supplement
12:00am